Key takeaways

  • Check the baseline and next blood-test date. ACE’s CKD Table 1 gives two to four weeks as an example interval for creatinine, eGFR and potassium, with closer checks when acute kidney injury risk is higher. Illness and other medicines affect the result. ACE CKD guidance
  • Report a persistent dry cough; treat face or throat swelling as urgent. Tongue or lip swelling can indicate angioedema and needs emergency assessment, especially with breathing difficulty. MedlinePlus
  • Review pregnancy and interacting medicines promptly. Dehydration, NSAIDs, potassium supplements or salt substitutes and an accidental ACE-inhibitor/ARB combination can change safety. ACE hypertension guidance

ACE inhibitors: cough, potassium, kidneys and monitoring

ACE Inhibitors: Cough, Potassium, Kidneys and Monitoring

What does an ACE inhibitor do?

An ACE inhibitor reduces formation of angiotensin II, which narrows blood vessels and promotes sodium retention. ACE stands for angiotensin-converting enzyme. The result can lower blood pressure and reduce strain on the heart. In chronic kidney disease with albumin in the urine, the pathway can also reduce pressure within the kidney’s filtering units.

Examples in this catalogue include ramipril, lisinopril, enalapril and perindopril. They share a class mechanism, but ingredient, strength, indication and dosing plan are not interchangeable.

Singapore’s ACE chronic-kidney-disease guideline identifies an ACE inhibitor or ARB as a main treatment option for people with CKD and albuminuria when clinically appropriate. The hypertension guideline also includes ACE inhibitors among common first-line classes. The hypertension guideline’s supplementary table lists pregnancy as a contraindication and kidney-function decline, high potassium, cough and angioedema among the class concerns. The same class mechanism does not make someone else’s prescription appropriate.

Why are kidney function and potassium checked?

The team compares creatinine, eGFR and potassium with the baseline after treatment starts or changes. ACE’s CKD Table 1 gives two to four weeks as an example interval, with closer monitoring for higher acute-kidney-injury risk. ACE inhibition changes kidney blood flow and potassium handling, so an early change can be predictable. Dehydration, infection, low pressure, renal-artery disease or interacting medicines may also affect the result.

In Table 1, an estimated glomerular filtration rate (eGFR) fall of at least 25% on starting an ACE inhibitor or ARB may require cessation or specialist shared care. A creatinine increase of more than 30% at any point requires investigation of the cause; adjustment or cessation may follow. Treatment need not be discontinued for a GFR decline below 25% from baseline, according to the guidance. Potassium, symptoms and the other findings are still reviewed.

Systolic pressure below 110 mmHg or symptoms of hypotension also prompt consideration of an adjustment in Table 1. Where applicable, the clinician adjusts other antihypertensives first, preserving the ACE inhibitor or ARB. These thresholds are for clinical assessment. Keep follow-up appointments and report illness; do not use the numbers to decide when to stop or restart medication.

Monitoring itemWhat the clinical team is checking
Blood pressure and symptomsWhether the intended effect is accompanied by faintness or low pressure
Creatinine and eGFRHow kidney filtration has changed from the person’s baseline
PotassiumWhether potassium has risen outside the safe range
Fluid status and other medicinesWhether illness, dehydration, diuretics, NSAIDs or supplements explain added risk

The blood-pressure medicine comparison shows why this laboratory pattern differs from amlodipine or a thiazide-type diuretic.

Why can an ACE inhibitor cause a dry cough?

The dry, persistent cough is thought to involve bradykinin and related peptides accumulating when ACE no longer breaks them down as readily. It may begin soon after treatment or appear after the medicine has been used for some time. A cough is not automatically caused by the tablet: asthma, reflux, infection, smoking and heart or lung disease can look similar.

The MedlinePlus patient guide notes that a cough can begin after an ACE inhibitor has been taken for some time. It may settle; sometimes the prescriber reduces the dose or changes the medicine. Report the cough and leave any adjustment to the prescriber. ACE’s CKD Table 1 suggests considering an ARB after assessing cough.

Do not treat the cough with repeated combination cold products without checking their active ingredients. Some contain decongestants or duplicate other medicines, while suppressing the symptom does not answer whether the ACE inhibitor is involved.

When is swelling more urgent than cough?

Face, lip, tongue or throat swelling can be angioedema, an uncommon but potentially life-threatening reaction. Swelling of the lips, tongue, face or throat, hoarseness, trouble swallowing or difficulty breathing needs emergency assessment. Call 995 in Singapore for breathing difficulty or rapidly progressing swelling. Do not wait for an ordinary clinic appointment or test whether an antihistamine is enough.

Give every prescriber the name of any ACE inhibitor that previously caused angioedema and describe the swelling. MedlinePlus directs patients with swollen lips or tongue to immediate medical help or the emergency department. Ankle swelling, more often associated with certain calcium-channel blockers, and an isolated dry cough have different causes and urgency. With a combination tablet, identify all ingredients.

Which medicines and everyday products affect the risk?

NSAIDs and potassium-containing products need checking before use. MedlinePlus specifically names ibuprofen and aspirin as medicines to discuss with the prescriber first. NSAIDs can reduce kidney blood flow, especially during dehydration or with a diuretic. Potassium tablets and potassium-containing salt substitutes can compound potassium elevation. Diuretics, other blood-pressure medicines and acute illness can contribute to low pressure or kidney stress. Include over-the-counter medicines, traditional remedies and supplements in the review.

Ramipril is an ACE inhibitor; losartan and valsartan are ARBs. An ACE inhibitor reduces angiotensin II formation, while an ARB blocks its receptor. Both act on the renin-angiotensin system. ACE’s hypertension Table 4 lists combining these classes as a risk for high potassium, acute kidney injury and excessive blood-pressure lowering.

Read every generic name on combination packs and older packets still being used; a brand name can conceal duplicate treatment.

If vomiting, diarrhoea, fever or poor fluid intake occurs, follow the individual’s written sick-day or clinic instructions. A general web page cannot decide whether the medicine should be held because the answer depends on the illness, kidney function, indication and other treatment.

Why does pregnancy require an early medicine review?

ACE inhibitors can harm a developing foetus and are not used during pregnancy. Pregnancy planning should therefore include a medication review before conception where possible. If pregnancy occurs or may have occurred while taking an ACE inhibitor, contact the prescriber promptly for a safe replacement plan; do not improvise a gap or use another person’s medicine.

The same review should cover breastfeeding, contraception plans and all other cardiovascular medicines. MedlinePlus advises people who are pregnant or planning pregnancy to contact their healthcare professional about ACE-inhibitor treatment.

What changes the answer?

The indication, laboratory trend, illness, other medicines and pregnancy determine the plan.

  • The reason for treatment. Hypertension, heart failure and albuminuric CKD have different expected benefits and follow-up priorities.
  • The baseline and trend. One creatinine or potassium result cannot be interpreted without previous results and timing.
  • Acute illness or dehydration. Vomiting, diarrhoea, fever and poor intake can rapidly change kidney perfusion.
  • Other medicines. NSAIDs, diuretics, potassium products, ARBs and mineralocorticoid-receptor antagonists can alter risk.
  • Pregnancy or pregnancy planning. This requires prompt prescriber-led replacement rather than routine continuation.
  • Cough or swelling pattern. A stable dry cough and rapidly progressing tongue swelling are not the same urgency.

What should you bring to a monitoring review?

Bring the packets or ingredient-and-strength list, test results and dates of illness or new symptoms. Include home blood-pressure readings if requested. Ask when the next kidney-function and potassium tests are due and who will review the results.

Seek prompt assessment for fainting, markedly reduced urine, severe weakness, palpitations or worsening illness. Use emergency care for facial, tongue or throat swelling, trouble breathing, chest pain or collapse.

Do and don’t

Do:

  • Confirm when the next creatinine, eGFR and potassium checks are due and who will review them.
  • Tell the team about vomiting, diarrhoea, poor intake, pregnancy plans and all non-prescription products.

Don’t:

  • Borrow a tablet, lower the dose for cough or improvise a sick-day pause.
  • Wait for a routine appointment with face or throat swelling or breathing difficulty.

Sources